Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

OPC-14117 effective in mouse model of motor neuron disease

May 23, 1997

Cortex to evaluate CX-516 for the treatment of schizophrenia

May 23, 1997

Results from a comparative study of olanzapine and risperidone reported

May 22, 1997

First launch for Quadramet

May 22, 1997

NMDA antagonist/opiate combination provides superior analgesia to morphine alone

May 22, 1997

Pfizer reports prodrugs of NMDA antagonist

May 22, 1997

Glaxo Wellcome describes optically active pyrimidine useful as analgesic and anticonvulsant

May 22, 1997

Atypical neuroleptics from Merck KGaA

May 22, 1997

NIH funds Cognetix's research on antiseizure drug

May 21, 1997

Serzone superior to Prozac in the treatment of sleep disturbances in depressed patients

May 21, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 29, 2026.
TROP2 ADCs progress into first-line for lung, breast cancers
BioWorld
Multiple updates on TROP2-directed antibody-drug conjugates (ADCs) for lung and breast cancers highlight both progress made and opportunities for improvement for...
Researchers identify innate immune barrier against melanoma
BioWorld
Australian researchers have identified a previously overlooked population of immune cells in the skin that physically restrain melanoma growth by engulfing live...
Cavalon Therapeutics and Northwestern patent new Cav1.3 blockers
BioWorld Science
Cavalon Therapeutics Inc. and Northwestern University have disclosed new voltage-gated calcium channel Cav1.3 blockers potentially useful for the treatment of...
In the clinic for May 26, 2026
BioWorld
Clinical updates for biopharma and med tech, including data readouts and publications: 858, A2 Biotherapeutics, AC Immune, Agendia, Agenus, Aktis, Ascentage,...